Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
- PMID: 27048634
- PMCID: PMC4823436
- DOI: 10.1136/bmjopen-2015-009986
Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
Abstract
Objective: To assess the effects of use of cannabis during pregnancy on maternal and fetal outcomes.
Data sources: 7 electronic databases were searched from inception to 1 April 2014. Studies that investigated the effects of use of cannabis during pregnancy on maternal and fetal outcomes were included.
Study selection: Case-control studies, cross-sectional and cohort studies were included.
Data extraction and synthesis: Data synthesis was undertaken via systematic review and meta-analysis of available evidence. All review stages were conducted independently by 2 reviewers.
Main outcomes and measures: Maternal, fetal and neonatal outcomes up to 6 weeks postpartum after exposure to cannabis. Meta-analyses were conducted on variables that had 3 or more studies that measured an outcome in a consistent manner. Outcomes for which meta-analyses were conducted included: anaemia, birth weight, low birth weight, neonatal length, placement in the neonatal intensive care unit, gestational age, head circumference and preterm birth.
Results: 24 studies were included in the review. Results of the meta-analysis demonstrated that women who used cannabis during pregnancy had an increase in the odds of anaemia (pooled OR (pOR)=1.36: 95% CI 1.10 to 1.69) compared with women who did not use cannabis during pregnancy. Infants exposed to cannabis in utero had a decrease in birth weight (low birth weight pOR=1.77: 95% CI 1.04 to 3.01; pooled mean difference (pMD) for birth weight=109.42 g: 38.72 to 180.12) compared with infants whose mothers did not use cannabis during pregnancy. Infants exposed to cannabis in utero were also more likely to need placement in the neonatal intensive care unit compared with infants whose mothers did not use cannabis during pregnancy (pOR=2.02: 1.27 to 3.21).
Conclusions and relevance: Use of cannabis during pregnancy may increase adverse outcomes for women and their neonates. As use of cannabis gains social acceptance, pregnant women and their medical providers could benefit from health education on potential adverse effects of use of cannabis during pregnancy.
Keywords: PREVENTIVE MEDICINE; PUBLIC HEALTH.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
Similar articles
-
Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study.Am J Obstet Gynecol. 2024 Jul;231(1):132.e1-132.e13. doi: 10.1016/j.ajog.2023.11.1232. Epub 2023 Nov 27. Am J Obstet Gynecol. 2024. PMID: 38029850 Free PMC article.
-
Treating periodontal disease for preventing adverse birth outcomes in pregnant women.Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD005297. doi: 10.1002/14651858.CD005297.pub3. Cochrane Database Syst Rev. 2017. PMID: 28605006 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Iodine supplementation for women during the preconception, pregnancy and postpartum period.Cochrane Database Syst Rev. 2017 Mar 5;3(3):CD011761. doi: 10.1002/14651858.CD011761.pub2. Cochrane Database Syst Rev. 2017. PMID: 28260263 Free PMC article.
-
Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes.Cochrane Database Syst Rev. 2018 Aug 31;8(8):CD012610. doi: 10.1002/14651858.CD012610.pub2. Cochrane Database Syst Rev. 2018. PMID: 30168868 Free PMC article.
Cited by
-
Marijuana use and pregnancy outcomes among women with hypertension in pregnancy.J Matern Fetal Neonatal Med. 2022 Jun;35(12):2286-2293. doi: 10.1080/14767058.2020.1785422. Epub 2020 Jul 6. J Matern Fetal Neonatal Med. 2022. PMID: 32627608 Free PMC article.
-
The Effects of Cannabis on Female Reproductive Health Across the Life Course.Cannabis Cannabinoid Res. 2021 Aug;6(4):275-287. doi: 10.1089/can.2020.0065. Epub 2020 Dec 28. Cannabis Cannabinoid Res. 2021. PMID: 33998877 Free PMC article.
-
Adverse Impact of Cannabis on Human Health.Annu Rev Med. 2024 Jan 29;75:353-367. doi: 10.1146/annurev-med-052422-020627. Epub 2023 Aug 15. Annu Rev Med. 2024. PMID: 37582489 Free PMC article. Review.
-
Use of Herbal Medicine by Pregnant Women: What Physicians Need to Know.Front Pharmacol. 2020 Jan 9;10:1483. doi: 10.3389/fphar.2019.01483. eCollection 2019. Front Pharmacol. 2020. PMID: 31998122 Free PMC article. Review.
-
Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.Am J Obstet Gynecol. 2017 Oct;217(4):478.e1-478.e8. doi: 10.1016/j.ajog.2017.05.050. Epub 2017 May 31. Am J Obstet Gynecol. 2017. PMID: 28578174 Free PMC article.
References
-
- WHO. Management of substance abuse: Cannabis. 7 July 2015. http://www.who.int/substance_abuse/facts/cannabis/en/
-
- Crime, U.N.O.o.D.a. World drug report. 2014. http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf
-
- Board, I.N.C, U.N.V.I. Centre, and Austria. International Narcotics Control Board: 2013 Annual Report, 2013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous